Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACIFIC: EP547 for Cholestatic Pruritus in PBC or PSC
NCT05525520Phase 2Completed
- Sponsor
- Escient Pharmaceuticals
- Start
- Oct 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of EP547 in cholestatic pruritus, sponsored by Escient Pharmaceuticals. Started Oct 2022; status: completed.
02
Drugs
EP547
03
Conditions
cholestatic pruritus
Beyond the preview
Go deeper on NCT05525520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05525520.